Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray

Parasitology

Volumn 134, Issue 6, 2007, Pages 777-787

  Singh, N ^a   Almeida, R ^b   Kothari, H ^a   Kumar, P ^a   Mandal, G ^c   Chatterjee, M ^c   Venkatachalam, S ^d   Govind, M K ^d   Mandal, S K ^a   Sundar, S ^e  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^d Connexios Life Sciences ^*  (India)

^e BANARAS HINDU UNIVERSITY   (India)

Author keywords

Clinical isolates; Drug resistance; Flow cytometry; Leishmania; Microarray

Indexed keywords

ANTIMONY GLUCONATE; MULTIDRUG RESISTANCE PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CONTROLLED STUDY; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PRIORITY JOURNAL; PROTOZOON; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIMONY SODIUM GLUCONATE; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, NORTHERN; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, PROTOZOAN; HUMANS; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS, VISCERAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SULFHYDRYL COMPOUNDS;

LEISHMANIA DONOVANI; LEISHMANIA MAJOR; NASO HEXACANTHUS;

EID: 34248397955     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182007002284     Document Type: Article

References (44)

1. Akopyants, N. S., Matlib, R. S., Bukanova, E. N., Smeds, M. R., Brownstein, B. H., Stormo, G. D. and Beverly, S. M. (2004). Expression profiling using random genomic DNA microarrays identifies deferentially expressed genes associated with three major developmental stages of the protozoan parasite Leishmania major. Molecular and Biochemical Parasitology 136, 71-86.
2. Alexander, J. and Russell, D. G. (1992). The interaction of Leishmania species with macrophages. Advances in Parasitology 31, 175-254.
3. Almeida, R., Gilmartin, B. J., McCann, S. H., Norrish, A., Ivens, A. C., Lawson, D., Levick, M. P., Smith, D. F., Dyall, S. D., Vetrie, D., Freeman, T. C., Coulson, R. M., Sampaio, I., Schneider, H. and Blackwell, J. M. (2004). Expression profiling of the Leishmania life cycle: cDNA arrays identify developmentally regulated genes present but not annotated in the genome. Molecular and Biochemical Parasitology 136, 87-100.
4. Beverley, S. M., Akopyants, N. S., Goyard, S., Matlib, R. S., Gordon, J. L., Brownstein, B. H., Stormo, G. D., Bukanova, E. N., Hott, C. T., Li, F., Macmillan, S., Muo, J. N., Schwertman, l. A., Smeds, M. R. and Wang, Y. (2002). Putting the Leishmania genome to work: functional genomics by transposon trapping and expression profiling. Philosophical Transactions of The Royal Society of London, B 357, 47-53.
5. Callahan, H. L. and Beverley, S. M. (1991). Heavy metal resistance: a new role for P-glycoproteins in Leishmania. Journal of Biological Chemistry 266, 18427-18430.
6. Cheok, M. H., Yang, W., Pui, C. H., Downing, J. R., Cheng, C., Naeve, C. W., Relling, M. V. and Evens, W. E. (2003). Treatment specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nature Genetics 34, 85-90.
7. Chiquero, M. J., Perez-Victoria, J. M., O'valle, F., Gonzalez-Ros, J. M., del Moral, R. G., Ferragut, J. A., Castanys, S. and Gamarro, F. (1998). Altered drug membrane permeability in a multidrug-resistant Leishmania tropica line. Biochemical Pharmacology 55, 131-139.
8. Chomezynski, P. and Sacchi, N. (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162, 156-159.
9. Chulay, J. D. and Bryceson, A. D. M. (1983). Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Americal Journal of Tropical Medicine and Hygyiene 32, 475-479.
10. Cleveland, W. S. (1979). Robust locally weighted regression and smoothing scatterplots. Journal of the American Statistical Association 74, 829-836.
11. Croft, S. L. and Coombs, G. H. (2003). Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends in Parasitology 19, 502-508.
12. Dey, S., Papadopoulou, B., Haimeur, A., Roy, G., Grondin, K., Dou, D., Rosen, B. P. and Ouellette, M. (1994). High level of arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Molecular and Biochemical Parasitology 67, 49-57.
13. Diehl, S., Diehl, F., El-Sayed, N. M., Clayton, C. and Hoheisel, J. D. (2002). Analysis of stage specific gene expression in the bloodstream and the procyclic form of Trypanosoma brucei using a genomic DNA- microarray. Molecular and Biochemical Parasitology 123, 115-123.
14. Dube, A., Singh, N., Sundar, S. and Singh, N. (2005). Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persists in in vitro and in vivo experimental models. Parasitology Research 96, 216-223.
15. El Fadili, K., Messier, N., Leprohon, P., Roy, G., Guimond, C., Trudel, N., Sarvia, N. G., Papadopoulou, B., Legare, D. and Ouellette, M. (2005). Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrobial Agents and Chemotherapy 49, 1988-1993.
16. Ephros, M., Bitnun, A., Shaked, P., Waldman, E. and Zilberstein, D. (1999). Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrobial Agents and Chemotherapy 43, 278-282.
17. Essodaigui, M., Broxterman, H. J. and Garnier-Suillerot, A. (1998). Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37, 2243-2250.
18. Gourbal, B., Sonuc, N., Bhattacharjee, H., Legare, D., Sundar, S., Ouellette, M., Rosen, B. P. and Mukhopadhyay, R. (2004). Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. Journal of Biological Chemistry 279, 31010-31017.
19. Grondin, K., Haimeur, A., Mukhopadhayay, R., Rosen, B. P. and Ouellette, M. (1997). Co-amplification of the gamma - glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite - resistant Leishmania tarentole. EMBO Journal 16, 3057-3065.
20. Guimond, C., Trudel, N., Brochu, C., Marquis, N., El Fadili, A., Peytavi, R., Briand, G., Richard, D., Messier, N., Papadopoulou, B., Corbeil, J., Bergeron, M. G., Legare, D. and Ouellette, M. (2003). Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucleic Acids Research 31, 5886-5896.
21. Haimeur, A., Brochu, C., Genest, P., Papadopoulou, B. and Ouellette, M. (2000). Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate Sb(III) resistant Leishmania tarentole. Molecular and Biochemical Parasitology 108, 131-135.
22. Hochberg, Y. (2002). A sharper Bonferroni procedure for multiple test of significance. Biometrika 75, 800-802.
23. Homolya, L., Hollo, Z., Germann, U. A., Pastan, I., Gottesman, M. M. and Sarkadi, B. (1993). Fluorescent cellular indicators are extruded by the multidrug resistance protein. Journal of Biological Chemistry 268, 21493-21496.
24. Ilgoutz, S. C. and McConville, M. J. (2001). Function and assembly of the Leishmania surface coat. International Journal for Parasitology 31, 899-908.
25. Kerr, M. K. and Churchill, G. A. (2001). Bootstrapping cluster analysis: assessing the reliability of conclusions from microarray experiments. Proceedings of the National Academy of Sciences, USA 98, 8961-8965.
26. Kothari, H., Kumar, P., Sundar, S. and Singh, N. (2006). Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani. Parasitology International (in the Press).
27. Newton, M. A., Kendziroski, C. M., Richmond, C. S., Blattner, F. R. and Tsui, K. W. (2001). On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. Journal of Computational Biology 8, 37-52.
28. Pavlidis, P. and Noble, W. S. (2001). Analysis of strain and regional variation in gene expression in mouse brain. Genome Biology 2, r0042.1-r0042.15.
29. Perez-Victoria, F. J., Castanys, S. and Gamarro, F. (2003). Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug. Antimicrobial Agents and Chemotherapy 47, 2397-2403.
30. Perez-Victoria, J. M., Parodi-Talice, A., Torres, C., Gamarro, F. and Castanys, S. (2001). ABC transporters in the protozoan parasite Leishmania. International Microbiology 4, 159-166.
31. Perez-Victoria, J. M., Perez-Victoria, F. J., Parodi-Talice, A., Jimenez, I. A., Ravelo, A. G., Castanys, S. and Gamarro, F. (2001). Alkyl-lysophospholipid resistance in multidrug resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein like transporter modulator. Antimicrobial Agents and Chemotherapy 45, 2468-2474.
32. Quackenbush, J. (2002). Microarray data normalization and transformation Nature Genetics 32 (Suppl.), 496-501.
33. Rathod, P. K., Ganesan, K., Hayward, R. E., Bozdech, Z. and Derisi, J. L. (2002). DNA microarrays for malaria. Trends in Parasitology 18, 39-45.
34. Rutherford, K., Parkhill, J., Crook, J., Horsnell, T., Rice, P., Rajandream, M. A. and Barrel, B. (2000). Artemis: sequence visualization and annotation. Bioinformatics 16, 944-945.
35. Singh, N. (2002). Is there true Sb (V) resistance in Indian kala-azar field isolates ? Current Science 83, 101-102.
36. Singh, N. (2006). Drug resistance mechanisms in clinical isolates of Leishmania donovani. Indian Journal of Medical Research 123, 411-422.
37. Singh, N., Singh, R. T. and Sundar, S. (2003). Novel mechanisms of drug resistance in kala azar field isolates. Journal of Infectious Diseases 188, 600-607.
38. Singh, R., Kumar, D., Ramesh, V., Negi, N. S., Singh, S. and Salotra, P. (2006). Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. Journal of Infectious Diseases 194, 302-306.
39. Sundar, S. (2001). Drug resistances in Indian visceral leishmaniasis. Tropical Medicine and International Health 6, 849-854.
40. Sundar, S. and Murray, H. W. (2005). Availability of miltefosine for the treatment of kala-azar in India. Bulletin of the World Health Organization 83, no. 5, pp. 394-395.
41. Tan, P. K., Downey, T. J., Spitznagel, E. L. Jr., Eu, P., Fu, D., Dimitroy, D. S., Lempicki, R. A., Raaka, B. M. and Cam, M. C. (2003). Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Research 31, 5676-5684.
42. Versantvoor, C. H. M., Broxterman, H. J., Pinedo, H. M., De Vries, E. G., Feller, N., Kuiper, C. M. and Lankelma, J. (1992). Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Research 52, 17-23.
43. Wilson, M., Derisi, J., Kristensen, H. H., Imboden, P., Rane, S., Brown, P. O. and Schoolnik, G. K. (1999). Exploring drug induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proceedings of the National Academy of Sciences, USA 96, 12833-12838.
44. Yang, Y. H., Dudoit, S., Luu, P., Lin, D. M., Peng, V., Ngai, J. and Speed, T. P. (2002). Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Research 30, e15.